Healthcare Sector Stocks
The Healthcare sector has a total of 1051 stocks, with a combined market cap of $9.5 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.38.
Market Cap
9.5T
Revenue
4.67T
Profits
188.51B
PE Ratio
50.38
Profit Margin
4.04%
Dividend Yield
0.39%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.12T | 3.55% | 3,755,242 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 610.38B | -0.25% | 9,278,160 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 500.80B | 0.59% | 7,621,730 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 365.02B | 2.79% | 10,164,859 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 358.21B | -1.48% | 13,865,456 | 66.57B |
| 6 | NVS | Novartis AG | 288.46B | 2.38% | 2,090,443 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 260.99B | 2.87% | 4,404,063 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 257.53B | 3.46% | 3,963,103 | 46.34B |
| 9 | AMGN | Amgen Inc. | 234.65B | 1.86% | 4,625,785 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 195.13B | 2.49% | 8,288,267 | 30.46B |
| 11 | ABT | Abbott Laboratories | 181.14B | 2.29% | 12,747,613 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 174.66B | 2.89% | 14,775,008 | 50.34B |
| 13 | PFE | Pfizer Inc. | 167.80B | 0.79% | 32,890,960 | 63.70B |
| 14 | DHR | Danaher Corporation | 162.74B | 3.03% | 5,127,820 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 151.15B | 1.81% | 2,060,769 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 128.95B | 2.06% | 2,262,589 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 123.73B | 2.18% | 13,754,444 | 49.19B |
| 18 | CVS | CVS Health Corporation | 118.41B | 2.42% | 14,268,270 | 412.65B |
| 19 | MDT | Medtronic plc | 116.84B | 1.29% | 50,230,146 | 37.54B |
| 20 | MCK | McKesson Corporation | 116.43B | 2.26% | 728,668 | 410.98B |
| 21 | SYK | Stryker Corporation | 112.48B | 4.12% | 3,121,142 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 101.43B | -0.41% | 1,124,440 | 78.01B |
| 23 | GSK | GSK plc | 99.22B | 2.40% | 6,141,589 | 44.05B |
| 24 | SNY | Sanofi | 96.85B | 1.31% | 5,053,610 | 55.89B |
| 25 | MRNA | Moderna, Inc. | 94.42B | 4.51% | 17,313,521 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 92.91B | 0.08% | 1,517,417 | 201.11B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 79.52B | 2.31% | 798,909 | 15.53B |
| 28 | CI | The Cigna Group | 78.96B | 3.19% | 2,072,269 | 282.38B |
| 29 | COR | Cencora, Inc. | 65.15B | 1.56% | 1,589,705 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 63.97B | 2.65% | 15,866,174 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 62.84B | 2.31% | 4,387,231 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 58.75B | 2.41% | 2,055,479 | 254.25B |
| 33 | NTRA | Natera, Inc. | 58.35B | 2.54% | 1,206,988 | 2.71B |
| 34 | ARGX | argenx SE | 53.15B | 3.42% | 510,768 | 5.32B |
| 35 | BDX | Becton, Dickinson and Company | 52.78B | 2.58% | 1,973,618 | 22.48B |
| 36 | HUM | Humana Inc. | 51.90B | 1.12% | 1,043,593 | 145.68B |
| 37 | EW | Edwards Lifesciences Corporation | 50.78B | 1.91% | 4,681,095 | 6.51B |
| 38 | VEEV | Veeva Systems Inc. | 50.68B | 5.27% | 2,865,706 | 3.46B |
| 39 | A | Agilent Technologies, Inc. | 49.49B | 0.89% | 1,893,886 | 7.37B |
| 40 | MDLN | Medline Inc. | 48.08B | 1.78% | 7,660,181 | 29.94B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 47.91B | 0.96% | 9,409,593 | 17.32B |
| 42 | IQV | IQVIA Holdings Inc. | 44.61B | 3.45% | 1,457,043 | 16.98B |
| 43 | HLN | Haleon plc | 43.75B | 2.69% | 18,334,710 | 14.80B |
| 44 | WAT | Waters Corporation | 43.64B | 1.73% | 1,008,653 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 43.11B | 3.43% | 545,291 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 42.53B | 6.43% | 744,868 | 6.13B |
| 47 | RVMD | Revolution Medicines, Inc. | 40.57B | -2.20% | 1,568,745 | - |
| 48 | ILMN | Illumina, Inc. | 40.46B | -1.41% | 2,989,297 | 4.49B |
| 49 | CNC | Centene Corporation | 34.83B | 0.50% | 4,689,370 | 180.30B |
| 50 | BIIB | Biogen Inc. | 34.77B | 1.08% | 1,572,453 | 10.03B |
| 51 | RPRX | Royalty Pharma plc | 34.28B | 1.07% | 3,407,114 | 2.54B |
| 52 | RMD | ResMed Inc. | 34.07B | 2.95% | 1,106,555 | 5.65B |
| 53 | DXCM | DexCom, Inc. | 33.10B | 5.08% | 4,786,232 | 4.97B |
| 54 | MTD | Mettler-Toledo International Inc. | 32.84B | 1.85% | 260,093 | 4.13B |
| 55 | ZTS | Zoetis Inc. | 32.40B | 4.16% | 5,015,595 | 9.53B |
| 56 | ALC | Alcon Inc. | 32.12B | 4.24% | 2,399,570 | 10.86B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.78B | 2.75% | 3,747,975 | 21.27B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.32B | 4.26% | 1,257,475 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.96B | 2.23% | 390,450 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.40B | 2.45% | 1,002,728 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 26.36B | 2.44% | 542,029 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 24.88B | 1.96% | 1,225,512 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 24.59B | 1.25% | 4,565,911 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 23.23B | 0.27% | 545,401 | 3.15B |
| 65 | INCY | Incyte Corporation | 22.96B | 1.52% | 1,940,495 | 5.82B |
| 66 | BNTX | BioNTech SE | 22.66B | 1.74% | 1,079,960 | 3.03B |
| 67 | GMAB | Genmab A/S | 22.65B | 2.52% | 4,084,424 | 4.13B |
| 68 | GH | Guardant Health, Inc. | 22.26B | 1.77% | 1,329,362 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 22.15B | 1.30% | 676,880 | 21.81B |
| 70 | STE | STERIS plc | 21.87B | 3.25% | 838,582 | 6.04B |
| 71 | INSM | Insmed Incorporated | 21.67B | 1.45% | 3,346,619 | 1.14B |
| 72 | VTRS | Viatris Inc. | 20.93B | 4.47% | 8,385,302 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.00B | 2.84% | 1,858,648 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.55B | 1.94% | 391,773 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 17.26B | 1.70% | 2,374,865 | 2.91B |
| 76 | EXEL | Exelixis, Inc. | 15.57B | 3.02% | 2,773,890 | 2.44B |
| 77 | SOLV | Solventum Corporation | 14.96B | 0.69% | 1,146,087 | 8.31B |
| 78 | ASND | Ascendis Pharma A/S | 14.88B | -0.17% | 403,968 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.62B | 1.40% | 928,441 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 13.92B | 0.77% | 1,379,144 | 3.37B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 13.92B | 2.28% | 886,417 | 4.60B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 13.79B | 4.01% | 2,470,210 | 1.66B |
| 83 | ICLR | ICON Public Limited Company | 13.51B | 3.65% | 795,833 | 8.29B |
| 84 | BAX | Baxter International Inc. | 13.32B | 3.87% | 4,508,145 | 11.47B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 13.12B | 3.37% | 2,638,806 | 713.07M |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.99B | -1.56% | 2,019,863 | 14.37B |
| 87 | TEM | Tempus AI, Inc. | 12.83B | 4.11% | 6,667,532 | 1.43B |
| 88 | PEN | Penumbra, Inc. | 12.65B | 0.34% | 345,435 | 1.50B |
| 89 | EHC | Encompass Health Corporation | 12.60B | 0.96% | 1,111,159 | 6.21B |
| 90 | SMMT | Summit Therapeutics Inc. | 12.29B | 1.59% | 4,733,234 | - |
| 91 | CORT | Corcept Therapeutics Incorporated | 12.26B | -2.46% | 668,518 | 830.81M |
| 92 | SNN | Smith & Nephew plc | 12.13B | 4.34% | 1,938,303 | 6.30B |
| 93 | DVA | DaVita Inc. | 12.06B | 4.68% | 625,088 | 14.01B |
| 94 | ELAN | Elanco Animal Health Incorporated | 11.76B | 4.39% | 6,652,168 | 5.02B |
| 95 | FMS | Fresenius Medical Care AG | 11.72B | 2.74% | 1,462,151 | 22.19B |
| 96 | TECH | Bio-Techne Corporation | 11.37B | 0.03% | 2,403,838 | 1.22B |
| 97 | MOH | Molina Healthcare, Inc. | 11.07B | 1.58% | 771,042 | 42.47B |
| 98 | UHS | Universal Health Services, Inc. | 11.04B | 0.79% | 490,421 | 18.11B |
| 99 | COO | The Cooper Companies, Inc. | 10.91B | 4.59% | 2,885,677 | 4.24B |
| 100 | AVTR | Avantor, Inc. | 10.88B | 2.48% | 5,968,952 | 6.56B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.85B | 1.65% | 2,922,503 | 3.41B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.74B | 1.18% | 2,745,241 | 3.50B |
| 103 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.62B | -0.04% | 266,191 | 1.28B |
| 104 | ALGN | Align Technology, Inc. | 10.61B | 3.39% | 1,140,836 | 4.14B |
| 105 | IBRX | ImmunityBio, Inc. | 10.60B | 0.91% | 20,010,110 | 165.79M |
| 106 | GMED | Globus Medical, Inc. | 10.59B | 3.32% | 1,835,460 | 3.14B |
| 107 | RGEN | Repligen Corporation | 10.39B | 3.35% | 1,043,053 | 785.10M |
| 108 | OSCR | Oscar Health, Inc. | 10.32B | -2.48% | 5,097,847 | 15.32B |
| 109 | ENSG | The Ensign Group, Inc. | 10.29B | 1.29% | 343,798 | 5.49B |
| 110 | PCVX | Vaxcyte, Inc. | 10.27B | -3.38% | 2,448,480 | - |
| 111 | KRYS | Krystal Biotech, Inc. | 9.77B | -0.21% | 288,017 | 440.48M |
| 112 | GKOS | Glaukos Corporation | 9.76B | -1.36% | 778,596 | 612.84M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.75B | 0.66% | 247,832 | 2.59B |
| 114 | HSIC | Henry Schein, Inc. | 9.69B | 1.67% | 963,228 | 13.60B |
| 115 | PODD | Insulet Corporation | 9.62B | 3.61% | 1,658,499 | 3.05B |
| 116 | QGEN | Qiagen N.V. | 9.55B | 1.34% | 1,312,644 | 2.10B |
| 117 | TXG | 10x Genomics, Inc. | 9.43B | -0.97% | 4,316,668 | 616.91M |
| 118 | TWST | Twist Bioscience Corporation | 9.06B | -2.48% | 3,542,966 | 431.80M |
| 119 | KYMR | Kymera Therapeutics, Inc. | 8.99B | 1.23% | 820,992 | 105.00M |
| 120 | CAI | Caris Life Sciences, Inc. | 8.98B | 4.97% | 3,554,257 | 989.61M |
| 121 | CYTK | Cytokinetics, Incorporated | 8.89B | 0.77% | 1,665,168 | 67.67M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.84B | 0.20% | 707,740 | 281.99M |
| 123 | BRKR | Bruker Corporation | 8.61B | 1.69% | 2,106,396 | 3.50B |
| 124 | AXSM | Axsome Therapeutics, Inc. | 8.47B | -0.27% | 802,617 | 776.57M |
| 125 | HNGE | Hinge Health, Inc. | 8.47B | -0.04% | 1,687,271 | 720.06M |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.26B | 0.22% | 2,009,594 | 669.50M |
| 127 | ABVX | ABIVAX Société Anonyme | 8.00B | 5.00% | 1,521,568 | 5.33M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.94B | 3.00% | 1,808,506 | 799.54M |
| 129 | ATR | AptarGroup, Inc. | 7.90B | 3.32% | 359,532 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.65B | 2.94% | 735,477 | 1.36B |
| 131 | PACS | PACS Group, Inc. | 7.56B | 6.16% | 1,697,733 | 5.55B |
| 132 | SYRE | Spyre Therapeutics, Inc. | 7.49B | 1.87% | 1,148,032 | - |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.33B | 3.33% | 2,485,000 | 874.09M |
| 134 | PRAX | Praxis Precision Medicines, Inc. | 6.93B | 3.86% | 632,946 | 7.46M |
| 135 | HIMS | Hims & Hers Health, Inc. | 6.85B | 5.99% | 16,305,227 | 2.58B |
| 136 | ALKS | Alkermes plc | 6.73B | 2.61% | 1,976,643 | 1.67B |
| 137 | GRFS | Grifols, S.A. | 6.72B | 4.14% | 907,080 | 8.48B |
| 138 | CHE | Chemed Corporation | 6.71B | 0.44% | 139,111 | 2.60B |
| 139 | AMRX | Amneal Pharmaceuticals, Inc. | 6.70B | 1.85% | 4,449,515 | 3.12B |
| 140 | IOVA | Iovance Biotherapeutics, Inc. | 6.67B | 3.59% | 11,518,942 | 324.97M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.01% | 866,503 | 1.56B |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.24B | 1.40% | 1,485,073 | 840.85M |
| 143 | BLTE | Belite Bio, Inc | 6.15B | -0.07% | 195,859 | - |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.06B | 1.45% | 644,561 | 239.92M |
| 145 | GRAL | GRAIL, Inc. | 6.05B | -3.04% | 701,512 | 165.26M |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | 1.19% | 332,112 | 290.54M |
| 147 | BLCO | Bausch + Lomb Corporation | 5.95B | 3.87% | 898,886 | 5.32B |
| 148 | IMVT | Immunovant, Inc. | 5.68B | -1.40% | 1,649,312 | - |
| 149 | DOCS | Doximity, Inc. | 5.61B | 5.28% | 3,132,813 | 655.57M |
| 150 | RDNT | RadNet, Inc. | 5.54B | 1.81% | 461,231 | 2.27B |
| 151 | KOD | Kodiak Sciences Inc. | 5.53B | 8.67% | 1,395,443 | - |
| 152 | HAE | Haemonetics Corporation | 5.52B | 0.15% | 747,648 | 1.35B |
| 153 | CGON | CG Oncology, Inc. | 5.48B | 0.03% | 1,186,401 | 6.23M |
| 154 | TFX | Teleflex Incorporated | 5.43B | 4.00% | 906,958 | 2.25B |
| 155 | WAY | Waystar Holding Corp. | 5.41B | 5.10% | 3,547,306 | 1.21B |
| 156 | MIRM | Mirum Pharmaceuticals, Inc. | 5.35B | 3.04% | 605,246 | 618.07M |
| 157 | MMSI | Merit Medical Systems, Inc. | 5.35B | 2.77% | 707,240 | 1.58B |
| 158 | STVN | Stevanato Group S.p.A. | 5.26B | -0.31% | 428,513 | 1.40B |
| 159 | ERAS | Erasca, Inc. | 5.20B | 1.16% | 8,481,042 | - |
| 160 | SHC | Sotera Health Company | 5.16B | 1.92% | 2,429,992 | 1.22B |
| 161 | COGT | Cogent Biosciences, Inc. | 5.12B | 4.83% | 3,039,765 | - |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.09B | 2.21% | 1,051,890 | 1.01B |
| 163 | MMED | MiniMed Group, Inc. | 5.06B | 7.08% | 27,733,245 | 3.22B |
| 164 | CON | Concentra Group Holdings Parent, Inc. | 4.99B | 4.51% | 1,655,903 | 2.29B |
| 165 | CRSP | CRISPR Therapeutics AG | 4.98B | 2.59% | 1,352,946 | 13.39M |
| 166 | TVTX | Travere Therapeutics, Inc. | 4.98B | -0.90% | 1,980,622 | 591.33M |
| 167 | SRRK | Scholar Rock Holding Corporation | 4.95B | 2.63% | 1,944,768 | - |
| 168 | ORKA | Oruka Therapeutics, Inc. | 4.89B | -3.66% | 1,222,110 | - |
| 169 | BLLN | BillionToOne, Inc. | 4.85B | 4.96% | 427,230 | 397.41M |
| 170 | MANE | Veradermics, Incorporated | 4.81B | 1.41% | 689,001 | - |
| 171 | LFST | LifeStance Health Group, Inc. | 4.73B | -1.20% | 3,535,915 | 1.58B |
| 172 | RGC | Regencell Bioscience Holdings Limited | 4.72B | 17.39% | 1,917,693 | - |
| 173 | OPCH | Option Care Health, Inc. | 4.68B | 0.32% | 4,116,832 | 5.69B |
| 174 | DFTX | Definium Therapeutics, Inc. | 4.60B | 0.06% | 1,747,570 | - |
| 175 | HTFL | HeartFlow, Inc. | 4.43B | 2.92% | 1,503,990 | 212.07M |
| 176 | LIVN | LivaNova PLC | 4.32B | 3.18% | 737,976 | 1.47B |
| 177 | ITGR | Integer Holdings Corporation | 4.31B | 0.09% | 497,607 | 1.84B |
| 178 | ICUI | ICU Medical, Inc. | 4.18B | 2.79% | 239,473 | 2.16B |
| 179 | DNTH | Dianthus Therapeutics, Inc. | 4.17B | -0.31% | 943,576 | 1.90M |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.15B | 3.19% | 1,837,468 | - |
| 181 | ABCL | AbCellera Biologics Inc. | 4.11B | 2.51% | 5,759,737 | 66.17M |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.08B | -0.16% | 1,734,427 | 308.08M |
| 183 | INDV | Indivior Pharmaceuticals, Inc. | 3.97B | -1.58% | 1,751,197 | 1.33B |
| 184 | NHC | National HealthCare Corporation | 3.85B | 4.71% | 95,879 | 1.56B |
| 185 | LEGN | Legend Biotech Corporation | 3.84B | 3.99% | 1,574,590 | 1.27B |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.83B | 2.30% | 2,903,890 | 53.81M |
| 187 | RLAY | Relay Therapeutics, Inc. | 3.79B | 1.41% | 2,117,119 | 10.35M |
| 188 | NVST | Envista Holdings Corporation | 3.77B | 2.98% | 3,673,602 | 2.86B |
| 189 | TLX | Telix Pharmaceuticals Limited | 3.70B | -0.75% | 220,693 | 890.79M |
| 190 | ARQT | Arcutis Biotherapeutics, Inc. | 3.66B | 10.19% | 3,955,755 | 463.98M |
| 191 | OGN | Organon & Co. | 3.61B | 0.15% | 1,980,089 | 6.13B |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.60B | 3.11% | 371,482 | 825.34M |
| 193 | VCYT | Veracyte, Inc. | 3.57B | 2.02% | 1,227,168 | 561.90M |
| 194 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.47B | 2.29% | 882,656 | -665.00K |
| 195 | CDNA | CareDx, Inc. | 3.45B | 3.07% | 1,302,477 | 458.09M |
| 196 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | 2.39% | 1,767,169 | 1.14B |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.32B | 1.27% | 1,618,739 | 7.50M |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.27B | -0.03% | 1,341,912 | 234.13M |
| 199 | PLSE | Pulse Biosciences, Inc. | 3.25B | -1.58% | 425,633 | 1.19M |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.19B | 7.46% | 5,225,270 | - |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12B | -1.80% | 1,398,351 | 606.33M |
| 202 | LQDA | Liquidia Corporation | 3.11B | 2.47% | 7,225,386 | 450.91M |
| 203 | PBLS | Parabilis Medicines, Inc. | 3.11B | -2.74% | 955,214 | 148.00K |
| 204 | WRBY | Warby Parker Inc. | 3.04B | -1.32% | 4,089,220 | 911.61M |
| 205 | CELC | Celcuity Inc. | 2.95B | 0.67% | 2,123,480 | - |
| 206 | ATRC | AtriCure, Inc. | 2.94B | 0.84% | 850,922 | 569.62M |
| 207 | DNLI | Denali Therapeutics Inc. | 2.93B | 2.63% | 1,566,183 | 3.60M |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.91B | 1.29% | 1,210,182 | 117.00M |
| 209 | ACHC | Acadia Healthcare Company, Inc. | 2.89B | -1.99% | 1,886,473 | 3.37B |
| 210 | PRVA | Privia Health Group, Inc. | 2.89B | 4.38% | 2,002,087 | 2.36B |
| 211 | ELVN | Enliven Therapeutics, Inc. | 2.88B | 0.13% | 2,053,739 | - |
| 212 | DYN | Dyne Therapeutics, Inc. | 2.86B | 1.66% | 2,074,626 | - |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.76B | 2.27% | 1,861,849 | 2.60B |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.73B | 5.41% | 3,754,018 | 701.94M |
| 215 | NEOG | Neogen Corporation | 2.68B | 1.15% | 2,877,398 | 884.00M |
| 216 | TMDX | TransMedics Group, Inc. | 2.65B | 1.32% | 1,132,588 | 668.47M |
| 217 | ZLAB | Zai Lab Limited | 2.64B | 4.49% | 823,986 | 449.61M |
| 218 | PGEN | Precigen, Inc. | 2.58B | -2.24% | 3,952,801 | 85.72M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | -2.22% | 443,998 | 1.46B |
| 220 | HCM | HUTCHMED (China) Limited | 2.49B | 3.41% | 51,861 | 549.12M |
| 221 | CLOV | Clover Health Investments, Corp. | 2.49B | -2.30% | 3,368,812 | 2.48B |
| 222 | BEAM | Beam Therapeutics Inc. | 2.47B | 4.57% | 1,779,870 | 156.04M |
| 223 | NAMS | NewAmsterdam Pharma Company N.V. | 2.46B | 3.05% | 881,956 | 7.12M |
| 224 | MBX | MBX Biosciences, Inc. | 2.44B | 3.87% | 601,768 | - |
| 225 | BKD | Brookdale Senior Living Inc. | 2.41B | -0.20% | 8,076,975 | 2.93B |
| 226 | ADMA | ADMA Biologics, Inc. | 2.40B | 3.77% | 2,772,376 | 512.28M |
| 227 | BHC | Bausch Health Companies Inc. | 2.36B | 7.13% | 2,306,065 | 10.85B |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.33B | 1.65% | 533,927 | 1.10B |
| 229 | UFPT | UFP Technologies, Inc. | 2.30B | 2.09% | 100,522 | 631.64M |
| 230 | SUPN | Supernus Pharmaceuticals, Inc. | 2.30B | -1.52% | 1,013,119 | 830.44M |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -4.55% | 4,655,499 | - |
| 232 | PRGO | Perrigo Company plc | 2.29B | 3.32% | 3,308,183 | 4.14B |
| 233 | CLDX | Celldex Therapeutics, Inc. | 2.27B | 3.92% | 1,181,697 | 158.00K |
| 234 | RXRX | Recursion Pharmaceuticals, Inc. | 2.23B | 11.23% | 62,870,086 | 54.86M |
| 235 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | 2.03% | 798,333 | 959.90M |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 0.72% | 1,034,774 | 311.51M |
| 237 | NEO | NeoGenomics, Inc. | 2.22B | 2.19% | 1,315,008 | 766.30M |
| 238 | VRDN | Viridian Therapeutics, Inc. | 2.22B | 6.42% | 2,167,912 | 71.13M |
| 239 | MD | Pediatrix Medical Group, Inc. | 2.20B | 2.59% | 479,089 | 1.95B |
| 240 | IRON | Disc Medicine, Inc. | 2.17B | 1.63% | 699,763 | - |
| 241 | FTRE | Fortrea Holdings Inc. | 2.16B | 6.58% | 2,910,404 | 2.68B |
| 242 | ADUS | Addus HomeCare Corporation | 2.13B | -0.11% | 172,424 | 1.48B |
| 243 | NVAX | Novavax, Inc. | 2.11B | 1.42% | 7,366,884 | 413.80M |
| 244 | PGNY | Progyny, Inc. | 2.11B | -1.38% | 1,057,256 | 1.31B |
| 245 | VCEL | Vericel Corporation | 2.10B | 1.91% | 601,208 | 306.30M |
| 246 | WGS | GeneDx Holdings Corp. | 2.09B | 2.35% | 796,647 | 454.43M |
| 247 | AXGN | Axogen, Inc. | 2.09B | 1.39% | 986,003 | 251.17M |
| 248 | BFLY | Butterfly Network, Inc. | 2.09B | 3.29% | 4,101,173 | 112.14M |
| 249 | PHVS | Pharvaris N.V. | 2.08B | -1.27% | 820,425 | - |
| 250 | VERA | Vera Therapeutics, Inc. | 2.06B | 6.84% | 1,526,592 | - |
| 251 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.05B | -0.37% | 4,504,339 | 940.61M |
| 252 | INSP | Inspire Medical Systems, Inc. | 2.03B | 3.01% | 621,177 | 898.74M |
| 253 | TRLV | Trulieve Cannabis Corp. | 1.98B | 3.31% | 1,418,748 | 1.14B |
| 254 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.73% | 283,371 | 6.13M |
| 255 | IMNM | Immunome, Inc. | 1.98B | 1.16% | 1,621,275 | 4.02M |
| 256 | ASTH | Astrana Health, Inc. | 1.95B | 0.82% | 260,519 | 3.84B |
| 257 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | 4.36% | 2,048,392 | 98.34M |
| 258 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 1.80% | 227,156 | 1.13B |
| 259 | SGRY | Surgery Partners, Inc. | 1.92B | -0.40% | 2,369,457 | 3.37B |
| 260 | MLYS | Mineralys Therapeutics, Inc. | 1.91B | 4.24% | 1,093,941 | - |
| 261 | SDGR | Schrödinger, Inc. | 1.91B | 1.72% | 2,372,983 | 259.04M |
| 262 | ALMR | Alamar Biosciences, Inc. | 1.90B | 8.08% | 1,260,863 | 100.42M |
| 263 | LMAT | LeMaitre Vascular, Inc. | 1.90B | 0.65% | 297,901 | 262.43M |
| 264 | ALVO | Alvotech | 1.90B | 2.71% | 1,156,272 | 494.61M |
| 265 | SRPT | Sarepta Therapeutics, Inc. | 1.88B | 5.70% | 4,041,905 | 1.97B |
| 266 | XERS | Xeris Biopharma Holdings, Inc. | 1.84B | 3.07% | 1,941,741 | 335.41M |
| 267 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.84B | 7.94% | 2,367,227 | 208.78M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.83B | 3.88% | 240,971 | - |
| 269 | ESTA | Establishment Labs Holdings Inc. | 1.83B | 6.01% | 484,390 | 245.82M |
| 270 | ZYME | Zymeworks Inc. | 1.83B | 3.96% | 751,932 | 37.13M |
| 271 | URGN | UroGen Pharma Ltd. | 1.79B | 0.08% | 636,574 | 188.73M |
| 272 | MESO | Mesoblast Limited | 1.79B | 1.16% | 290,027 | 120.25M |
| 273 | XNCR | Xencor, Inc. | 1.78B | 2.61% | 726,920 | 104.97M |
| 274 | VIR | Vir Biotechnology, Inc. | 1.77B | 0.58% | 1,417,938 | 303.23M |
| 275 | XRAY | DENTSPLY SIRONA Inc. | 1.76B | 4.62% | 5,182,809 | 3.64B |
| 276 | SEPN | Septerna, Inc. | 1.75B | 3.11% | 271,438 | 98.88M |
| 277 | BHVN | Biohaven Ltd. | 1.73B | 4.57% | 1,448,269 | - |
| 278 | TRVI | Trevi Therapeutics, Inc. | 1.73B | 0.41% | 1,709,232 | - |
| 279 | ARDT | Ardent Health, Inc. | 1.72B | 2.09% | 537,642 | 6.41B |
| 280 | KMTS | Kestra Medical Technologies, Ltd. | 1.71B | 12.60% | 405,479 | 106.73M |
| 281 | PSNL | Personalis, Inc. | 1.70B | 0.19% | 2,141,087 | 69.67M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.70B | 0.22% | 352,900 | 481.07M |
| 283 | ALHC | Alignment Healthcare, Inc. | 1.69B | -0.97% | 8,978,384 | 4.58B |
| 284 | ATEC | Alphatec Holdings, Inc. | 1.69B | 4.69% | 3,051,548 | 815.05M |
| 285 | NVCR | NovoCure Limited | 1.68B | 4.12% | 1,810,878 | 699.19M |
| 286 | GENB | Generate Biomedicines, Inc. | 1.68B | 4.31% | 975,150 | 26.48M |
| 287 | NUVB | Nuvation Bio Inc. | 1.67B | 1.50% | 4,823,073 | 169.90M |
| 288 | ZBIO | Zenas BioPharma, Inc. | 1.66B | 2.17% | 471,939 | 1.00M |
| 289 | OMCL | Omnicell, Inc. | 1.64B | 1.58% | 393,009 | 1.25B |
| 290 | OCUL | Ocular Therapeutix, Inc. | 1.62B | 2.50% | 3,252,526 | 52.06M |
| 291 | CMPS | COMPASS Pathways plc | 1.61B | 3.11% | 2,806,316 | - |
| 292 | AZTA | Azenta, Inc. | 1.60B | -1.78% | 1,217,356 | 613.81M |
| 293 | BRVE | Braveheart Bio, Inc. | 1.60B | 1.09% | 206,065 | - |
| 294 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -0.79% | 6,528,998 | 59.51M |
| 295 | STOK | Stoke Therapeutics, Inc. | 1.59B | 5.80% | 818,176 | 27.59M |
| 296 | GPCR | Structure Therapeutics Inc. | 1.58B | 1.42% | 1,414,161 | - |
| 297 | QURE | uniQure N.V. | 1.56B | 7.39% | 1,613,125 | 18.67M |
| 298 | AMN | AMN Healthcare Services, Inc. | 1.55B | 6.21% | 1,203,208 | 3.43B |
| 299 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | 3.02% | 240,988 | 978.38M |
| 300 | PAHC | Phibro Animal Health Corporation | 1.54B | 0.13% | 184,696 | 1.52B |
| 301 | KRSA | Korsana Biosciences, Inc. | 1.53B | -1.95% | 176,035 | - |
| 302 | MAZE | Maze Therapeutics, Inc. | 1.53B | 4.77% | 540,016 | 20.00M |
| 303 | ABSI | Absci Corporation | 1.52B | 1.60% | 3,395,650 | 1.56M |
| 304 | COAG | Hemab Therapeutics Holdings, Inc. | 1.52B | 8.62% | 478,283 | - |
| 305 | IMCR | Immunocore Holdings plc | 1.52B | 4.02% | 378,198 | 430.78M |
| 306 | KLRA | Kailera Therapeutics, Inc. | 1.52B | 9.03% | 1,174,646 | - |
| 307 | INVA | Innoviva, Inc. | 1.51B | -0.52% | 672,982 | 440.00M |
| 308 | RARE | Ultragenyx Pharmaceutical Inc. | 1.49B | 1.81% | 3,332,836 | 717.00M |
| 309 | AGL | agilon health, inc. | 1.49B | 1.20% | 137,434 | 5.92B |
| 310 | PNTG | The Pennant Group, Inc. | 1.48B | 3.55% | 400,538 | 1.10B |
| 311 | CERT | Certara, Inc. | 1.47B | 3.21% | 1,658,188 | 421.75M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.47B | 1.95% | 521,743 | 1.86B |
| 313 | ETON | Eton Pharmaceuticals, Inc. | 1.47B | -2.93% | 462,321 | 105.60M |
| 314 | ANAB | AnaptysBio, Inc. | 1.46B | 4.37% | 416,305 | 106.09M |
| 315 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.19% | 2,064,239 | 746.16M |
| 316 | RAPP | Rapport Therapeutics, Inc. | 1.42B | 4.38% | 334,900 | 20.00M |
| 317 | CNMD | CONMED Corporation | 1.41B | 4.92% | 401,286 | 1.37B |
| 318 | AAPG | Ascentage Pharma Group International | 1.39B | -1.08% | 8,958 | 94.61M |
| 319 | NUTX | Nutex Health Inc. | 1.38B | 1.98% | 141,361 | 846.72M |
| 320 | OMER | Omeros Corporation | 1.36B | 1.95% | 931,368 | 38.42M |
| 321 | INBX | Inhibrx Biosciences, Inc. | 1.33B | 6.15% | 226,452 | 1.30M |
| 322 | ORIC | ORIC Pharmaceuticals, Inc. | 1.32B | 10.18% | 1,557,456 | - |
| 323 | FRNM | Freenome, Inc. | 1.32B | 0.78% | 782,732 | 35.41M |
| 324 | TYRA | Tyra Biosciences, Inc. | 1.31B | 1.82% | 418,029 | - |
| 325 | KARD | Kardigan, Inc. | 1.30B | 2.66% | 660,930 | - |
| 326 | GHRS | GH Research PLC | 1.29B | 1.35% | 276,721 | - |
| 327 | NKTR | Nektar Therapeutics | 1.29B | 2.25% | 684,250 | 54.59M |
| 328 | TRAX | First Tracks Biotherapeutics, Inc. | 1.29B | 5.60% | 1,578,956 | - |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.28B | 1.26% | 302,801 | 804.27M |
| 330 | INNV | InnovAge Holding Corp. | 1.23B | -1.10% | 307,892 | 989.71M |
| 331 | SNDX | Syndax Pharmaceuticals, Inc. | 1.22B | 0.89% | 2,626,218 | 252.25M |
| 332 | TSHA | Taysha Gene Therapies, Inc. | 1.22B | 6.27% | 4,685,719 | 5.49M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.22B | -2.52% | 620,392 | - |
| 334 | SVRA | Savara Inc. | 1.20B | -0.42% | 1,691,414 | - |
| 335 | OPK | OPKO Health, Inc. | 1.20B | 17.52% | 55,454,763 | 587.90M |
| 336 | GDRX | GoodRx Holdings, Inc. | 1.20B | 3.70% | 1,901,250 | 785.23M |
| 337 | LBRX | LB Pharmaceuticals Inc | 1.18B | 7.91% | 976,646 | - |
| 338 | CRON | Cronos Group Inc. | 1.18B | 1.27% | 807,893 | 179.09M |
| 339 | BCAX | Bicara Therapeutics Inc. | 1.17B | 1.61% | 662,062 | - |
| 340 | BVS | Bioventus Inc. | 1.16B | 2.30% | 295,606 | 581.85M |
| 341 | DMRA | Damora Therapeutics, Inc. | 1.16B | 1.68% | 357,931 | - |
| 342 | AHG | Akso Health Group | 1.16B | -1.82% | 2,145 | 13.83M |
| 343 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 3.19% | 4,590,450 | 1.04B |
| 344 | VOR | Vor Biopharma Inc. | 1.14B | 3.15% | 696,787 | - |
| 345 | OMDA | Omada Health, Inc. | 1.14B | 2.47% | 1,624,597 | 309.76M |
| 346 | IRMD | IRADIMED CORPORATION | 1.14B | -0.51% | 80,634 | 86.34M |
| 347 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.12B | 1.30% | 352,436 | 730.02M |
| 348 | NBTX | Nanobiotix S.A. | 1.12B | 4.46% | 116,354 | 13.15M |
| 349 | VSTM | Verastem, Inc. | 1.12B | 19.71% | 16,959,024 | 87.53M |
| 350 | STAA | STAAR Surgical Company | 1.12B | 1.92% | 626,109 | 339.59M |
| 351 | ENOV | Enovis Corporation | 1.12B | 4.20% | 1,294,435 | 2.30B |
| 352 | REPL | Replimune Group, Inc. | 1.11B | 3.16% | 1,613,748 | - |
| 353 | AVLN | Avalyn Pharma Inc. | 1.09B | 4.01% | 199,363 | - |
| 354 | TDOC | Teladoc Health, Inc. | 1.08B | 2.75% | 2,933,173 | 2.49B |
| 355 | HROW | Harrow, Inc. | 1.08B | 5.54% | 583,475 | 275.59M |
| 356 | AORT | Artivion, Inc. | 1.07B | 1.58% | 512,464 | 471.47M |
| 357 | CBLL | CeriBell, Inc. | 1.06B | 4.82% | 911,794 | 101.96M |
| 358 | JANX | Janux Therapeutics, Inc. | 1.06B | 1.11% | 546,902 | 24.00M |
| 359 | IART | Integra LifeSciences Holdings Corporation | 1.05B | 2.66% | 1,334,172 | 1.65B |
| 360 | PRCT | PROCEPT BioRobotics Corporation | 1.04B | 3.66% | 1,247,819 | 337.34M |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.04B | 2.08% | 371,349 | 1.04B |
| 362 | HSTM | HealthStream, Inc. | 1.03B | 0.30% | 246,339 | 321.12M |
| 363 | CSTL | Castle Biosciences, Inc. | 1.03B | 2.08% | 381,941 | 357.28M |
| 364 | MNKD | MannKind Corporation | 1.03B | 5.63% | 3,756,601 | 393.63M |
| 365 | LTGO | Latigo Biotherapeutics, Inc. | 978.58M | 5.43% | 242,899 | - |
| 366 | IMTX | Immatics N.V. | 975.97M | 2.00% | 1,629,203 | 47.65M |
| 367 | QDEL | QuidelOrtho Corporation | 953.88M | 0.29% | 2,000,135 | 2.67B |
| 368 | MGTX | MeiraGTx Holdings plc | 949.87M | 5.10% | 836,397 | 397.50M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 942.14M | 5.52% | 164,911 | - |
| 370 | BBNX | Beta Bionics, Inc. | 911.23M | 2.61% | 1,331,132 | 119.01M |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 900.97M | 2.64% | 972,109 | - |
| 372 | IAM | Iambic Therapeutics, Inc. | 896.35M | 18.19% | 2,015,122 | 18.25M |
| 373 | SIBN | SI-BONE, Inc. | 892.34M | 2.26% | 467,244 | 213.60M |
| 374 | AKTS | Aktis Oncology, Inc. | 890.47M | -2.91% | 667,741 | 10.06M |
| 375 | ANRO | Alto Neuroscience, Inc. | 887.66M | 4.19% | 529,857 | - |
| 376 | SLBT | SL Science Holding Limited | 883.91M | - | 130,674 | 3.27M |
| 377 | RIGL | Rigel Pharmaceuticals, Inc. | 882.62M | 0.92% | 167,855 | 276.79M |
| 378 | JBIO | Jade Biosciences, Inc. | 875.10M | 2.38% | 1,038,874 | - |
| 379 | MLTX | MoonLake Immunotherapeutics | 873.19M | 1.18% | 1,067,279 | - |
| 380 | GLUE | Monte Rosa Therapeutics, Inc. | 863.37M | 2.85% | 1,543,915 | 28.73M |
| 381 | KURA | Kura Oncology, Inc. | 862.92M | 0.94% | 1,676,990 | 77.23M |
| 382 | AHCO | AdaptHealth Corp. | 852.48M | 2.24% | 1,611,360 | 3.36B |
| 383 | ABUS | Arbutus Biopharma Corporation | 848.77M | 2.39% | 2,276,650 | 181.72M |
| 384 | ODTX | Odyssey Therapeutics, Inc. | 841.93M | 5.84% | 159,239 | 99.00K |
| 385 | CRVS | Corvus Pharmaceuticals, Inc. | 828.59M | 5.01% | 1,000,175 | - |
| 386 | AVBP | ArriVent BioPharma, Inc. | 827.88M | 3.64% | 815,703 | - |
| 387 | SGP | SpyGlass Pharma, Inc. | 826.83M | 4.35% | 47,120 | - |
| 388 | INMD | InMode Ltd. | 823.12M | 0.28% | 633,857 | 374.63M |
| 389 | ALMS | Alumis Inc. | 816.74M | 4.13% | 2,786,515 | 7.40M |
| 390 | ARDX | Ardelyx, Inc. | 814.84M | 2.51% | 4,072,158 | 450.89M |
| 391 | GMRS | GMR Solutions Inc. | 807.53M | -3.08% | 366,510 | 5.88B |
| 392 | HELP | Helus Pharma Inc. | 807.31M | 6.45% | 1,534,458 | - |
| 393 | DNA | Ginkgo Bioworks Holdings, Inc. | 791.92M | 1.99% | 2,330,100 | 132.42M |
| 394 | GERN | Geron Corporation | 790.24M | 3.36% | 5,678,554 | 204.56M |
| 395 | ANL | Adlai Nortye Group Ltd. | 778.57M | 11.12% | 864,173 | 18.06M |
| 396 | VREX | Varex Imaging Corporation | 778.47M | 0.44% | 574,056 | 865.00M |
| 397 | APMD | Apnimed, Inc. | 759.55M | 5.89% | 260,260 | 115.12M |
| 398 | COLL | Collegium Pharmaceutical, Inc. | 754.64M | 2.98% | 1,001,997 | 808.21M |
| 399 | OBX | Obsidian Therapeutics, Inc. | 753.63M | -0.16% | 240,337 | - |
| 400 | IVA | Inventiva S.A. | 750.45M | 8.36% | 2,911,748 | 2.81M |
| 401 | SANA | Sana Biotechnology, Inc. | 740.92M | 6.22% | 2,916,353 | - |
| 402 | LXRX | Lexicon Pharmaceuticals, Inc. | 734.18M | 3.12% | 1,433,570 | 41.47M |
| 403 | IMMX | Immix Biopharma, Inc. | 719.60M | 2.00% | 1,314,418 | - |
| 404 | ACHV | Achieve Life Sciences, Inc. | 717.23M | -0.43% | 1,197,730 | - |
| 405 | FDMT | 4D Molecular Therapeutics, Inc. | 710.99M | 5.49% | 787,614 | 92.01M |
| 406 | STLN | Starling Oncology, Inc. | 704.24M | 6.14% | 1,186,753 | 587.24M |
| 407 | CTKB | Cytek Biosciences, Inc. | 703.21M | 0.19% | 905,398 | 206.71M |
| 408 | OABI | OmniAb, Inc. | 687.70M | 3.96% | 820,688 | 38.46M |
| 409 | PHR | Phreesia, Inc. | 685.26M | 3.86% | 996,225 | 507.79M |
| 410 | PHAR | Pharming Group N.V. | 683.83M | -0.10% | 7,343 | 366.48M |
| 411 | ANNX | Annexon, Inc. | 682.48M | -1.91% | 2,653,846 | - |
| 412 | MDXG | MiMedx Group, Inc. | 682.16M | -0.43% | 1,331,063 | 355.17M |
| 413 | CADL | Candel Therapeutics, Inc. | 681.78M | -1.76% | 989,339 | - |
| 414 | GYRE | Gyre Therapeutics, Inc. | 678.62M | -1.08% | 108,766 | 109.82M |
| 415 | ATTO | Attovia Therapeutics, Inc. | 674.73M | -1.20% | 641,398 | 1.80M |
| 416 | AURA | Aura Biosciences, Inc. | 657.49M | 2.76% | 604,523 | - |
| 417 | DSGN | Design Therapeutics, Inc. | 655.86M | 7.71% | 503,990 | - |
| 418 | AVTX | Avalo Therapeutics, Inc. | 644.10M | 1.44% | 936,286 | 59.00K |
| 419 | PRME | Prime Medicine, Inc. | 642.23M | 15.34% | 6,299,859 | 4.07M |
| 420 | WVE | Wave Life Sciences, Inc. | 628.58M | 3.24% | 3,350,972 | 65.37M |
| 421 | CLYM | Climb Bio, Inc. | 626.63M | 6.03% | 515,488 | - |
| 422 | IRWD | Ironwood Pharmaceuticals, Inc. | 622.95M | 4.72% | 2,044,808 | 389.32M |
| 423 | SOPH | SOPHiA GENETICS SA | 620.58M | 3.26% | 1,757,626 | 86.17M |
| 424 | AVR | Anteris Technologies Global Corp. | 620.06M | 1.60% | 825,661 | 2.24M |
| 425 | NVCT | Nuvectis Pharma, Inc. | 616.77M | 5.17% | 156,864 | - |
| 426 | SLDB | Solid Biosciences Inc. | 615.47M | 4.94% | 2,033,374 | - |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 609.87M | 0.39% | 462,450 | 136.07M |
| 428 | PACB | Pacific Biosciences of California, Inc. | 609.23M | -1.51% | 12,620,913 | 159.27M |
| 429 | OLMA | Olema Pharmaceuticals, Inc. | 601.11M | 1.03% | 1,088,441 | - |
| 430 | PHAT | Phathom Pharmaceuticals, Inc. | 595.73M | 1.35% | 1,210,198 | 239.66M |
| 431 | WEAV | Weave Communications, Inc. | 591.19M | - | 1,095,105 | 257.79M |
| 432 | KIDS | OrthoPediatrics Corp. | 589.30M | 1.44% | 225,701 | 252.72M |
| 433 | FLGT | Fulgent Genetics, Inc. | 587.18M | 1.57% | 139,675 | 323.93M |
| 434 | CRMD | CorMedix Inc. | 581.46M | 0.95% | 1,466,253 | 462.25M |
| 435 | SGMT | Sagimet Biosciences Inc. | 579.32M | 8.21% | 1,367,240 | - |
| 436 | SLN | Silence Therapeutics plc | 562.96M | 4.12% | 2,567,486 | 615.00K |
| 437 | STTK | Shattuck Labs, Inc. | 555.01M | 3.75% | 867,831 | 1.00M |
| 438 | EVH | Evolent Health, Inc. | 550.60M | 2.96% | 3,837,699 | 2.10B |
| 439 | VALN | Valneva SE | 549.22M | 4.42% | 8,680 | 163.30M |
| 440 | ETRA | Electra Therapeutics, Inc. | 549.21M | -2.13% | 179,560 | - |
| 441 | PBYI | Puma Biotechnology, Inc. | 543.04M | 3.14% | 377,439 | 231.24M |
| 442 | DBVT | DBV Technologies S.A. | 538.06M | 2.71% | 432,283 | 5.04M |
| 443 | CBIO | Crescent Biopharma, Inc. | 534.16M | -0.79% | 295,936 | 11.88M |
| 444 | FTH | Faeth Therapeutics, Inc. | 532.31M | 3.00% | 231,652 | - |
| 445 | DRUG | Bright Minds Biosciences Inc. | 531.80M | 6.90% | 121,463 | - |
| 446 | TCMD | Tactile Systems Technology, Inc. | 527.57M | 3.93% | 211,415 | 350.31M |
| 447 | CTMX | CytomX Therapeutics, Inc. | 525.14M | 8.07% | 2,985,687 | 18.30M |
| 448 | SSII | SS Innovations International, Inc. | 516.99M | -4.44% | 29,207 | 52.40M |
| 449 | DCTH | Delcath Systems, Inc. | 513.89M | 0.61% | 214,873 | 95.42M |
| 450 | ACRS | Aclaris Therapeutics, Inc. | 513.72M | 3.25% | 2,587,484 | 8.22M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 509.58M | -11.93% | 5,469,789 | 54.09M |
| 452 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 453 | EVO | Evotec SE | 503.42M | -0.35% | 123,977 | 819.47M |
| 454 | EOLS | Evolus, Inc. | 500.00M | 4.85% | 901,465 | 316.49M |
| 455 | MASS | 908 Devices Inc. | 491.46M | 0.51% | 274,627 | 60.84M |
| 456 | ANGO | AngioDynamics, Inc. | 486.99M | 4.80% | 1,137,017 | 325.38M |
| 457 | SGHT | Sight Sciences, Inc. | 484.77M | 6.67% | 282,037 | 83.38M |
| 458 | MNPR | Monopar Therapeutics Inc. | 481.93M | -1.78% | 143,450 | - |
| 459 | ENTX | Entera Bio Ltd. | 481.77M | 10.80% | 1,447,906 | 42.00K |
| 460 | NGNE | Neurogene Inc. | 479.27M | 7.98% | 587,986 | 925.00K |
| 461 | YDES | YD Bio Limited | 477.40M | 5.97% | 72,327 | 1.24M |
| 462 | BLSM | BlossomHill Therapeutics, Inc. | 476.14M | -1.83% | 176,512 | - |
| 463 | RGNX | REGENXBIO Inc. | 472.65M | 4.07% | 1,228,634 | 174.48M |
| 464 | TLRY | Tilray Brands, Inc. | 470.79M | 2.23% | 2,670,166 | 963.10M |
| 465 | ARVN | Arvinas, Inc. | 468.17M | 4.99% | 606,046 | 316.70M |
| 466 | NRC | NRC Health | 466.94M | 3.33% | 98,469 | 140.00M |
| 467 | BWAY | BrainsWay Ltd. | 465.93M | 2.69% | 109,590 | 60.70M |
| 468 | ALLO | Allogene Therapeutics, Inc. | 462.96M | 3.08% | 4,515,193 | 4.64M |
| 469 | ALT | Altimmune, Inc. | 459.06M | 2.16% | 3,353,752 | 31.00K |
| 470 | AUTL | Autolus Therapeutics plc | 457.80M | 1.78% | 1,486,314 | 117.39M |
| 471 | OCS | Oculis Holding AG | 456.82M | 3.21% | 559,213 | 1.45M |
| 472 | CERS | Cerus Corporation | 455.45M | 0.89% | 2,122,681 | 221.55M |
| 473 | KMDA | Kamada Ltd. | 452.84M | 3.03% | 60,983 | 191.85M |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 447.05M | 2.73% | 594,850 | - |
| 475 | MPLT | MapLight Therapeutics, Inc. | 445.72M | 2.69% | 658,423 | - |
| 476 | OVID | Ovid Therapeutics Inc. | 441.37M | 3.20% | 1,333,288 | 1.58M |
| 477 | PROK | ProKidney Corp. | 439.88M | -1.02% | 1,109,236 | 818.00K |
| 478 | NPCE | NeuroPace, Inc. | 438.66M | 1.75% | 86,618 | 106.99M |
| 479 | PRTA | Prothena Corporation plc | 436.36M | 1.55% | 358,380 | 54.53M |
| 480 | SENS | Senseonics Holdings, Inc. | 435.15M | 1.60% | 678,246 | 48.55M |
| 481 | DMAC | DiaMedica Therapeutics Inc. | 433.56M | 4.96% | 303,895 | - |
| 482 | CAPR | Capricor Therapeutics, Inc. | 422.67M | 10.32% | 3,355,374 | 11.13M |
| 483 | ASMB | Assembly Biosciences, Inc. | 418.82M | 0.19% | 204,263 | 74.85M |
| 484 | TECX | Tectonic Therapeutic, Inc. | 416.40M | 1.62% | 187,394 | - |
| 485 | MYGN | Myriad Genetics, Inc. | 416.08M | 4.82% | 1,069,862 | 806.60M |
| 486 | RCEL | AVITA Medical, Inc. | 414.73M | 2.37% | 388,791 | 75.63M |
| 487 | AGMB | AgomAb Therapeutics NV | 410.24M | -4.14% | 97,715 | - |
| 488 | ZURA | Zura Bio Limited | 410.15M | -2.95% | 4,997,082 | - |
| 489 | RZLT | Rezolute, Inc. | 409.10M | -7.80% | 2,120,268 | - |
| 490 | EIKN | Eikon Therapeutics, Inc. | 408.40M | 7.56% | 657,561 | - |
| 491 | TKNO | Alpha Teknova, Inc. | 408.03M | -2.44% | 353,082 | 43.70M |
| 492 | CYH | Community Health Systems, Inc. | 405.23M | 0.34% | 756,402 | 11.98B |
| 493 | SPRY | ARS Pharmaceuticals, Inc. | 404.75M | 3.56% | 2,220,134 | 116.93M |
| 494 | CTEV | Claritev Corporation | 404.37M | -0.33% | 196,315 | 994.67M |
| 495 | AUNA | Auna S.A. | 392.27M | 0.95% | 162,452 | 1.37B |
| 496 | SCTX | Scribe Therapeutics Inc. | 392.26M | -0.24% | 180,871 | 33.30M |
| 497 | OFIX | Orthofix Medical Inc. | 390.63M | 3.68% | 317,972 | 833.19M |
| 498 | SRTA | Strata Critical Medical, Inc. | 383.95M | 1.40% | 925,915 | 255.98M |
| 499 | SI | Shoulder Innovations, Inc. | 382.44M | 2.80% | 81,023 | 60.06M |
| 500 | TRXB | TRex Bio, Inc. | 381.22M | 4.89% | 88,697 | - |